ET Healthcare, Inc. is an in vitro diagnostics company that manufactures central laboratory analyzers for inpatient and outpatient testing in hospitals, including pediatric, ICU, operating room, ER, cardiac, cancer, and birth clinics. It develops The Pylon Immunochemistry System, an integrated turnkey system that combines the central laboratory analyzer for point-of-care testing; Pylon Immunochemistry System that addresses immunodiagnostics needs, including inflammation, cardiac function, fertility, infectious diseases, drugs, and tumors; The Pylon BNP Immunoassay, which supports the management of heart failure patients and measures B-type natriuretic peptide in plasma; and immunoassays for a range of applications, such as cardiac markers, blood clots/thrombosis, fertility, and inflammation. The company is based in Palo Alto, California with offices in Shanghai, China; and manufacturing facilities in Suzhou, China.